default author photo

Fabrizio Maggi

University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi

Varese

Italy

SCHOLARLY PAPERS

3

DOWNLOADS

380

TOTAL CITATIONS

7

Scholarly Papers (3)

1.

Mucosal Immune Response in BNT162b2 COVID-19 Vaccine Recipients

Number of pages: 16 Posted: 29 Jun 2021
University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), Pisa University Hospital, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Department of Medicine and Surgery, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Chief Medical Officer, University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi” and University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”
Downloads 167 (449,518)
Citation 7

Abstract:

Loading...

BNT162b2 mRNA vaccine; COVID-19; SARS-CoV-2; saliva; IgA

2.

Immunological Signature in Human Cases of Monkeypox Infection in 2022 Outbreak

Number of pages: 20 Posted: 08 Sep 2022
Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Università degli studi di Modena e Reggio Emilia (UNIMORE) - Department of Medical and Surgical Sciences, and FIL Trial Office, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Università degli studi di Modena e Reggio Emilia (UNIMORE) - Department of Medical and Surgical Sciences, and FIL Trial Office, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Cellular Immunology and Clinical Pharmacology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Università degli studi di Modena e Reggio Emilia (UNIMORE) - Department of Medical and Surgical Sciences, and FIL Trial Office, affiliation not provided to SSRN, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Division of Infectious Diseases, National Institute for Infectious Diseases "Lazzaro Spallanzani" IRCCS, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Virology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Laboratory of Microbiology, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI, Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Lazzaro Spallanzani National Institute for Infectious Diseases - INMI and Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) - Clinical Department
Downloads 136 (537,489)

Abstract:

Loading...

Monkeypox, hiv, orthopox, immune response

3.

Mucosal Immune Response after the Booster Dose of the BNT162b2 COVID-19 Vaccine

Number of pages: 19 Posted: 08 Jun 2022
University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Research Centre in Epidemiology and Preventive Medicine (EPIMED), University of Insubria - Department of Medicine and Surgery, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, Chief Medical Officer, University of Insubria - Azienda Socio-Sanitaria Territoriale dei Sette Laghi, University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi” and University of Insubria - Laboratory of General Pathology and Immunology “Giovanna Tosi”
Downloads 77 (823,616)

Abstract:

Loading...

BNT162b2 mRNA vaccine, COVID-19, SARS-CoV-2, saliva, IgA